肺癌的分子特征——迈向个性化治疗 - Suppr

Suppr

超能文献

Molecular signatures of lung cancer--toward personalized therapy.

作者信息

Herbst Roy S, Lippman Scott M

出版信息

N Engl J Med. 2007 Jan 4;356(1):76-8. doi: 10.1056/NEJMe068218.

DOI:10.1056/NEJMe068218

PMID:17202459

Abstract

摘要

相似文献

Molecular signatures of lung cancer--toward personalized therapy.

N Engl J Med. 2007 Jan 4;356(1):76-8. doi: 10.1056/NEJMe068218.

Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer.

Clin Lung Cancer. 2005 Nov;7(3):163-5. doi: 10.1016/S1525-7304(11)70404-1.

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.

Nat Clin Pract Oncol. 2006 Apr;3(4):170-1. doi: 10.1038/ncponc0476.

A curious link between epidermal growth factor receptor amplification and survival: effect of "allele dilution" on gefitinib sensitivity?

J Natl Cancer Inst. 2005 May 4;97(9):621-3. doi: 10.1093/jnci/dji127.

[Mutations in the epidermal growth factor receptor and targeted therapy of non-small-cell lung cancer].

Zhonghua Bing Li Xue Za Zhi. 2005 Nov;34(11):745-6.

Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.

Lung Cancer. 2015 Mar;87(3):311-7. doi: 10.1016/j.lungcan.2015.01.004. Epub 2015 Jan 14.

Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives.

Future Oncol. 2017 Feb;13(3):201-204. doi: 10.2217/fon-2016-0325. Epub 2016 Sep 14.

First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation: positive non-small cell lung cancer patients.

J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S143-5. doi: 10.1097/JTO.0b013e318174e981.

The cellular origins of drug resistance in cancer.

Nat Med. 2016 Mar;22(3):232-4. doi: 10.1038/nm.4058.

The role of third-generation epithelial growth factor receptor inhibitors in non-small cell lung cancer.

Clin Adv Hematol Oncol. 2015 Mar;13(3):147-9.

引用本文的文献

circRNA circFAT1(e2) Elevates the Development of Non-Small-Cell Lung Cancer by Regulating miR-30e-5p and USP22.

Biomed Res Int. 2021 Apr 2;2021:6653387. doi: 10.1155/2021/6653387. eCollection 2021.

A meta-learning approach for genomic survival analysis.

Nat Commun. 2020 Dec 11;11(1):6350. doi: 10.1038/s41467-020-20167-3.

Correlation between combining F-FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer.

Eur J Nucl Med Mol Imaging. 2020 May;47(5):1183-1197. doi: 10.1007/s00259-019-04652-6. Epub 2020 Jan 3.

Utilization and Safety of Percutaneous Lung Biopsy: A 10-Year Nationwide Population-Based Study.

Int J Environ Res Public Health. 2019 Apr 12;16(8):1316. doi: 10.3390/ijerph16081316.

Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma.

Cell Res. 2016 Oct;26(10):1149-1164. doi: 10.1038/cr.2016.111. Epub 2016 Sep 27.

Increased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy.

PLoS One. 2015 Aug 7;10(8):e0134682. doi: 10.1371/journal.pone.0134682. eCollection 2015.

From tissue to molecular phenotyping: pre-analytical requirements heidelberg experience.

Transl Lung Cancer Res. 2012 Jun;1(2):111-21. doi: 10.3978/j.issn.2218-6751.2011.12.07.

Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses.

Onco Targets Ther. 2014 Nov 10;7:2061-5. doi: 10.2147/OTT.S72974. eCollection 2014.

DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling.

PLoS One. 2014 Mar 12;9(3):e91509. doi: 10.1371/journal.pone.0091509. eCollection 2014.

Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel.

PLoS One. 2013 Nov 13;8(11):e80478. doi: 10.1371/journal.pone.0080478. eCollection 2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验